SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioDelivery Sciences International, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - February 15, 2022) - Rigrodsky Law, P.A. is investigating BioDelivery Sciences International, Inc. ("BioDelivery") (NASDAQ: BDSI) regarding possible breaches of fiduciary duties and other violations of law related to BioDelivery's agreement to be acquired by Collegium Pharmaceutical, Inc. Under the terms of the agreement, BioDelivery's shareholders will receive $5.60 in cash for each share of BioDelivery common stock they own.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-biodelivery-sciences-international-inc.
You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or firstname.lastname@example.org.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113921